Design Therapeutics, Inc. announced the initiation of a Phase 1 clinical trial for its gene-targeted treatment DT-216P2 in healthy volunteers, with patient dosing for Friedreich Ataxia (FA) set to ...
Chemomab Therapeutics has announced that it has successfully completed its End-of-Phase 2 meeting with the FDA, aligning on the design of a single Phase 3 trial for its lead product candidate, ...
Last month’s column walked through the scenario of what might happen if the commissioning professional is not engaged until very late in the construction phase. This is a challenge on many fronts, but ...
The trial uses a response-driven dosing strategy and extended treatment across three prostate cancer populations, supported by the favorable clinical, pharmacokinetic and dosimetry results from ...
As biomarker studies employ increasingly complex and expensive genomics and other correlative methods, it is increasingly important to rigorously design these studies and analyze the downstream ...
What happens when there is a design change (change order) in the middle of functional performance testing? That late in the project, design changes are often a result of functional performance testing ...
A multi-million dollar design-build contract was approved on Wednesday for the first phase of Austin’s first light rail ...
Some brief theory and typical measurements of phase noise. Standard analysis of PLL phase noise used by most CAD applications. How to produce the lowest phase noise at a PLL output. A standard design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results